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Abstract
BACKGROUND—Suicide among college students is a significant public health concern.
Although suicidality is linked to depression, not all depressed college students experience suicidal
ideation (SI). The primary aim of this study was to determine potential factors that may
distinguish college students with depressive symptoms with and without SI.
METHODS—A total of 287 undergraduate college students with substantial depressive
symptoms (Beck Depression Inventory [BDI] total score >13) with and without SI were compared
across psychiatric and functional outcome variables. Independent sample t tests were conducted
for each outcome variable using the suicide item of the BDI as a dichotomous (ie, zero vs nonzero
score) grouping variable.
RESULTS—Relative to students with substantial depressive symptoms without SI, those with SI
were more symptomatic overall, having significantly higher levels of depressive symptoms,
hopelessness, and anxiety. However, contrary to our expectations, nonsuicidal and suicidal
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students did not differ on measures of everyday functioning (ie, cognitive and physical functioning
and grade point average).
CONCLUSIONS—Our findings suggest that SI among college students is associated with
increased subjective distress but may not adversely impact physical or cognitive functioning or
academic performance.
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suicide; depression; college students; anxiety; undergraduate; hopelessness
INTRODUCTION
College students are at elevated risk of suicidal thoughts and behaviors, perhaps because of
the numerous developmental challenges (internal) and psychosocial changes (external) they
experience. These challenges include exploring or developing their identity (eg, making
career choices), navigating the transition from a state of full dependence to a state of
semidependence on their parents, creating social relationships in a different environment,
managing the financial burden of increasingly high college tuition, and leaving their primary
support system.1 Although depressive symptoms are a well-known risk factor for suicidal
thoughts and behaviors, most people with depressive symptoms do not go on to consider
killing themselves.2 Therefore, there is a need to identify what factors may predict suicidal
ideation (SI) among those with elevated depressive symptoms.
We are aware of only 1 study comparing college students with and without current SI. The
study, which was part of an American Foundation for Suicide Prevention–sponsored College
Screening Project (n = 729), found that 11% of students endorsed current (past 4 weeks) SI
and 16.5% had a lifetime suicide attempt or self-injurious episode.3 Those with current SI
had higher depressive symptom severity (based on Patient Health Questionnaire–9 [PHQ-9]
scores) and anxiety, irritability, panic, rage, desperation, and functional impairment, and felt
more out of control compared with those without SI. As a limitation, the study measured the
strong and distressing emotional state items with single, nonvalidated items (ie, anxiety,
irritability, panic, rage, desperation, and feeling out of control), not construct-specific
instruments. This article represents an extension of that earlier study in that we examined
similar domains with validated outcome measures.
The primary aim of this study was to examine whether college students with substantial
depressive symptoms with and without SI differ across psychiatric and functional outcome
domains. Our primary hypothesis was that students with substantial depressive symptoms
and SI have greater symptom burden and functional impairment compared with students
with substantial depressive symptoms without SI. Similar findings were demonstrated in
youth age 7 to 17 in a previous study.4
METHODS
Participants
The 287 participants in this study represented a sub-sample of a larger study (N = 898)
conducted by the Depression Clinical and Research Program at the Massachusetts General
Hospital (MGH) Department of Psychiatry.5 Undergraduate students interested in
participating in a mental health screening signed consent forms approved by the institutional
review board at MGH and filled out self-report measures. Students were given a $10
voucher to their university bookstore as a reimbursement for their time. The analyses
reported here include only students endorsing substantial symptoms of depression6 (Beck
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Depression Inventory [BDI] ≥13). In brief, if students endorsed symptoms of depression
and/or suicidality, they were interviewed by a PhD/MD level clinician. The clinician
reviewed items and assessed students’ risk for self-harm or harm to others. Appropriate
referrals were provided, and if necessary, students were escorted to the mental health center
if deemed to be at imminent risk. This study was conducted over many years, and different
scales were used throughout the course of the study. As such, the total sample sizes for the
scales are not the same.
Measures
Demographics—A 4-page questionnaire was used to assess participant demographics,
including the demographic domains age, sex, school year, current grade point average
(GPA), marital status, living situation, ethnicity, and family socioeconomic status. Other
than age and GPA, the demographic information was collected categorically (see categorical
options in TABLE 1).
Depressive symptoms—The BDI6 is a 21-item measure of depression that includes
questions about core symptoms of depression (eg, sadness, guilt, disappointment, irritability,
suicidal thoughts, indecisiveness, insomnia, and loss of appetite). Each item is scored 0, 1, 2,
or 3, with higher scores indicating greater severity. Depressive symptom severity was
indexed based on the total score of the BDI without the BDI suicide item (BDI item 9), as
this was used as the grouping variable (independent variable).
Suicidal ideation—Item 9 of the BDI was used to assess the presence of SI within the
past week. The BDI suicide item includes 4 response choices, scored as follows: 0 = I don't
have any thoughts of killing myself; 1 = I have thoughts of killing myself, but I would not
carry them out; 2 = I would like to kill myself; and 3 = I would kill myself if I had the
chance (see TABLE 2 for frequencies).
Hopelessness—The Beck Hopelessness Scale7 (BHS) was used to assess participant
hopelessness. The BHS is a 20-item questionnaire that asks respondents to answer true or
false statements. Each statement reflects a positive or negative attitude regarding the future.
Higher scores indicate greater hopelessness.
Anxiety symptoms—Two measures were used to assess participant anxiety: the Anxiety
Symptom Questionnaire8,9 (ASQ) is a 17-item self-report questionnaire measuring the
frequency and intensity of 17 symptoms of anxiety, including nervousness, worrying,
irritability, trouble relaxing, insomnia, lack of energy, difficulty concentrating, somatic
symptoms, and impairment in functioning due to anxiety. In a college population, the ASQ
demonstrated high reliability (Cronbach α = 0.97, subscale α = 0.94) and discriminant
validity (the scale discriminated between patients with and without anxiety and also
depression, P values <.0001).9 The Beck Anxiety Inventory10 (BAI) is a 21-item scale
measuring the severity of self-reported anxiety in adults and adolescents. It includes
descriptive statements of anxiety symptoms rated on a 4-point scale as follows: 0 = Not at
all; 1 = Mildly; it did not bother me much; 2 = Moderately; it was very unpleasant, but I
could stand it; and 3 = Severely; I could barely stand it. Higher total scores indicate greater
anxiety.
Quality of life—Quality of Life Enjoyment and Satisfaction Questionnaire—Short Form11
(Q-LES-Q-Short Form): The Q-LES-Q-Short Form asks about physical health, general
feelings of well-being, work satisfaction, leisure activities, social relationships, and life
satisfaction over the past week. Participants are asked to rate their answers on a scale of 1 to
5, from “Very Poor” to “Very Good.” Answers in the “Very Good” range indicate greater
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satisfaction with life. A quality-of-life index score for the Q-LES-Q-Short Form is
calculated by averaging the scores of all 16 items, with higher scores indicating higher
quality of life.
Cognitive and physical functioning—The MGH Cognitive and Physical Functioning
Questionnaire12 (CPFQ) is a 7-item questionnaire for assessment of cognitive and physical
functioning. Higher overall scores indicate greater cognitive and executive dysfunction.
Data analysis
The analysis included 287 students (mean age, 19.81 ± 1.87; 64% female) with a BDI total
score >13. For all measures, descriptive statistics were calculated for the entire sample and
then separately for students with and without SI. If differences were found between the 2
groups in any demographic variables, these variables would be included as covariates in the
main analyses. The BDI suicide item was used in the independent samples t tests as the
dichotomous, grouping/independent variable, indicating the presence or absence of SI (zero
vs nonzero score). Previous studies have used the BDI suicide item in this manner.5,13-15 In
fact, Wenzel and colleagues demonstrated a relationship between a nonzero score on the
BDI suicide item and actual eventual death by suicide in a sample of patients hospitalized
for SI.14 The dependent variables included the BDI total (minus BDI suicide item 9), BHS
total, ASQ intensity total, ASQ frequency total, Q-LES-Q total, CPFQ total, and BAI total.
RESULTS
There were no differences between the 2 groups (with SI group: n = 124; without SI group:
n = 163) in demographic characteristics (TABLE 1). Mean BDI scores for the full sample
(N = 287) were 19.46 ± 6.67 (SD) for the BDI total score, and 18.98 ± 6.48 (SD) for the
BDI total score minus the BDI suicide item (BDI item 9). TABLE 2 shows the frequency of
students’ responses on the BDI suicide item.
TABLE 3 summarizes the results from the independent samples t tests comparing college
students with substantial depressive symptoms with and without SI across psychiatric and
functional outcome domains. The 2 groups differed in the expected direction across all
psychiatric outcome variables. Students with SI endorsed higher levels of hopelessness (P
< .01), more frequent anxiety (P < .01), more intense anxiety (P < .01), more intense general
anxiety (P < .01), and greater depressive severity (P < .01) compared with students without
SI. On the other hand, the 2 groups did not differ on functional domains, including quality of
life and cognitive and physical functioning. Of note, no differences in GPA were found in
students with and without SI.
Next we conducted post hoc analyses to further delineate the relationship between SI and
functional status, in order to examine the possibility that our initial dichotomous
categorization obscured differences between the 2 groups in these functional domains
(TABLE 4). We categorized students into 3 groups based on their response to the BDI
suicide item: no SI (score of 0), mild SI (score of 1), or moderate to severe SI (score of 2 or
3). Quality of life was significantly lower for those with moderate to severe SI vs those with
either mild SI or no SI (P < .05). However, cognitive and physical functioning and GPA did
not differ based on severity of SI.
DISCUSSION
The primary aim of this study was to determine potential factors that may distinguish
college students with depressive symptoms who think about suicide from those who do not.
Consistent with our hypotheses, those with SI had greater severity of psychiatric symptoms,
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including severity of depression, anxiety, and hopelessness, compared with those without SI.
Across our measures of functional domains (ie, cognitive and physical functioning, quality
of life, and GPA), students with and without SI did not differ; however, post hoc analyses
revealed that those with the highest levels of SI (moderate to severe SI) evidenced
impairments in quality of life relative to students with mild SI and no SI, suggesting that
suicidality in college students with substantial depressive symptoms may be associated with
reduced life satisfaction. This finding is considered exploratory, as are all of our post hoc
analyses, as our sample of students with the most severe level of SI was notably small. For
the Q-LES-Q finding in particular, there were only 5 students who had the most severe level
of suicidality. Our small sample may have also obscured potential findings in the opposite
direction—ie, the current study did not have the power to detect, for example, GPA
differences in the group with the most severe level of SI. The parent study examined some
similar variables5 within the entire population, whereas the present study examined only
students with a BDI score >13. Similar to Farabaugh et al,5 we found that hopelessness and
depressive severity were related to suicidality. However, we did not find the functional
deficits in this subsample.
Other studies of college populations do suggest an association between suicidality and
functioning. Garlow and colleagues3 found higher levels of self-reported global functional
impairment (measured with a single item from the original PHQ-9) in college students with
SI compared with those without SI. In a slightly older sample of medical students, quality of
life was significantly associated with SI.16 And in a sample of Korean college students,
academic decrement was associated with SI.17 Taken together, these results may suggest
that a greater subjective sense of reduced functioning/life satisfaction is associated with SI,
but measures of functioning that are less likely to be influenced by subjective distress, such
as those measuring physical and cognitive functioning, may not be adversely affected by SI.
It also is surprising that our study did not find functional differences between the groups,
given the established connection between depression and functional impairment/quality of
life in the general adult population.18 Perhaps the high stress of college makes SI more
prevalent and also less pathological—ie, not associated with functional impairment—in the
college student population. The present study may have captured the hypothesized
differences between the groups if a measure of social functioning had been obtained, as
constructs associated with social functioning have consistently been linked to suicidality in
the college student population.15,19-22 The association between social support and suicidality
has also been established in college student samples outside the United States.23
It is possible that we found no differences between the groups on functional impairment due
to the suicidal group underreporting their functional difficulty. In future studies, objective
measures of cognitive, social, and academic functioning could be used to determine whether
SI in college students with depressive symptoms is associated with impaired functioning
across domains. We did examine 1 objective measure of functioning—GPA; however, we
did not find a difference between the 2 groups. Although this finding must be considered
preliminary, given the limited power of the analysis, it may suggest that objective
measurements of functioning are relatively unaffected by the presence of SI in college
students with depressive symptoms.
The finding that students with SI experienced more anxiety than their peers without SI is
consistent with Wilcox and colleagues,15 who found that college students with current SI
had higher anxiety, irritability, and panic, and felt more out of control compared with those
without SI. However, they used single-item questions to measure anxiety, irritability, panic,
and feeling out of control. Here we replicate these findings within a college population using
validated (BAI) and preliminarily validated (ASQ) measures of anxiety. Although a number
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of studies have highlighted the importance of anxiety symptoms and risk for suicide,24,25 we
are unaware of any other studies examining the co-occurrence of symptoms of anxiety and
depression in relation to SI specifically in the college student population.
Our finding that depressive symptoms were higher for students with SI is consistent with
published literature on college populations. For example, in a study of SI in college students,
Konick and Gutierrez26 found that for 345 undergraduates, depressive symptoms (as
measured by the BDI) exerted a stronger influence on SI than did hopelessness (as measured
by the BHS). Garlow and colleagues3 found that college students with SI have higher levels
of depressive severity compared with those without SI. They utilized a different measure of
depression (PHQ-9), indicating that these results hold across different measures. Different
measures also were used to assess current SI in the 2 studies. Taken together, both studies
seem to demonstrate the relationship between higher depressive symptoms and SI, despite
varying methodologies.
Our finding that hopelessness is greater in students with SI is not surprising. Our study
replicated the well-documented finding that hopelessness is significantly associated with SI
in the general population.27-29 Although the literature is sparse, this finding has been
demonstrated in college populations as well.26,30
Forty-three percent of college students in our sample of students with substantial symptoms
of depression had current SI, meaning they endorsed at least a score of 1 on the BDI suicide
item (“I have thoughts of killing myself, but I would not carry them out”). Our rate is higher
than rates of SI observed in college populations not specifically selected for depressive
symptoms,3,13,15,31,32 likely because of including only students with substantial depressive
symptoms, making the presence of SI far more likely. Consistent with this hypothesis, and
similar to our findings, Garlow and colleagues3 found significantly higher rates of SI when
comparing students with and without substantial depressive symptoms (29% vs 6%).
Additionally, other studies may have used more stringent measures of SI.
Limitations
Our findings need to be interpreted within the context of the study's limitations. First, we
cannot draw any causal conclusions from the present study because it is only cross-sectional.
Second, our study used BDI suicide item 9 to assess current SI. This item is not a well-
validated or in-depth assessment of suicidality. Further findings might have emerged had we
conducted a more in-depth assessment of the 3 hypothesized domains of suicidality33 (ie,
cognitive, emotional, and behavioral). On the other hand, there is utility in using this
nonintrusive, easily administered measure of SI in an initial screening.5,15 Third, we relied
mostly on self-report measures to assess functioning. Real-world indicators of functioning
might have increased the validity and utility of the present results. Freshmen may have
reported their high school vs college GPA and therefore their GPA may not have been a
valid estimate of their current college-level academic functioning. Fourth, we also did not
assess the persistence of SI over time. Students in this study may have been one-time
ideators vs persistent ideators, and we were unable to examine this important
characteristic.15 Lastly, students who participated in the screenings of this study were self-
referred; therefore, students who are struggling with the greatest burden of depressive
symptoms may not have participated. As such, our findings may actually underestimate the
current degree of depressive symptoms and suicidality on college campuses.
Future directions
Future studies are needed to address the relationship between SI, depression, and functional
impairment in the college population. It is possible that specific symptoms of depression are
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more closely related to functional impairment than an overall depression score. Follow-up
studies also are needed to prospectively test for hypothesized links between psychiatric and
functional domains and actual real-world measures, such as suicide attempts. Additional
research also is needed to examine the added burden of anxiety symptoms (in addition to
depressive symptoms) because they appear to play a role in SI in this population.
Additionally, it may be helpful to further characterize students with SI without substantial
depressive symptoms. For example, Arria et al19 found that a majority of college students
with SI were not depressed. Moreover, future research could use in-depth suicide assessment
measures, especially as a second step to initial screening measures, to assess more complex
relationships among different aspects of suicidality. Lastly, future interventions may benefit
from targeting comorbid symptoms of anxiety and depression to reduce SI and suicide
attempts.
Clinically, we have 2 recommendations based on the findings of this study. First, suicidality
may in fact be a marker of greater symptom severity. Specifically, clinicians may not
consider comorbid symptoms of anxiety to be associated with suicidality. As such, clinicians
may undervalue the importance of monitoring and treating comorbid symptoms of anxiety
when students present with depressive symptoms. Second, SI often may go undetected in
this population, due in part to a lack of major functional impairment. Therefore, it is
important to ask about SI even when a student may not appear functionally impaired. Lack
of functional impairment in students with SI may be one of the reasons why suicide of
young people appears to occur unexpectedly.
CONCLUSIONS
The results of this study suggest that SI among college students with significant symptoms
of depression is associated with increased subjective distress but may not adversely impact
physical and cognitive functioning or academic performance.
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TABLE 1
Clinical and demographic variables
Variable
Total sample
N = 287
With SI
n = 124
Without SI
n = 163
Mean SD Mean SD Mean SD
Age (n = 269) 19.81 1.87 19.78 1.70 19.83 2.00
GPA (n = 242) 3.24 0.50 3.23 0.46 3.25 0.53
Sex (n = 276) n % n % n %
    Female 184 64.1% 72 58.1% 112 68.7%
    Male 92 32.1% 47 37.9% 45 27.6%
School year (n = 275) n % n % n %
    Freshman 74 25.8% 35 28.2% 39 23.9%
    Sophomore 73 25.4% 25 20.2% 48 29.4%
    Junior 70 24.4% 32 25.8% 38 23.3%
    Senior 49 17.1% 23 18.5% 26 16%
    Other 9 3.1% 4 3.2% 5 3.1%
Marital status (n = 276) n % n % n %
    Never married 273 95.1% 119 96% 154 94.5%
    Other 3 0.9% 5 4% 3 1.8%
Living situation (n = 112) n % n % n %
    On campus alone 33 11.5% 13 10.5% 20 12.3%
    On campus with roommates 34 11.8% 12 9.7% 22 13.5%
    Off campus alone 8 2.8% 3 2.4% 5 3.1%
    Off campus with relatives 8 2.8% 4 3.2% 4 2.5%
    Off campus with roommates 29 10.1% 13 10.5% 16 9.8%
Ethnicity (n = 249) n % n % n %
    Black, not of Hispanic origin 22 7.7% 9 7.3% 13 8%
    Hispanic 19 6.6% 4 3.2% 15 9.2%
    White, not of Hispanic origin 157 54.7% 68 54.8% 89 54.6%
    American Indian or Alaskan Native 1 0.3% 1 0.8% 0 0%
    Asian or Pacific Islander 36 12.5% 21 16.9% 15 9.2%
    Other 14 4.9% 5 4% 9 5.5%
Family socioeconomic status (n = 101) n % n % n %
    Low income (<$24,999) 6 2.1% 3 2.4% 3 1.8%
    Low-middle income ($25,000 to $49,000) 13 4.5% 6 4.8% 7 4.3%
    Middle income ($50,000 to $79,999) 29 10.1% 14 11.3% 15 9.2%
    Upper-middle income ($80,000 to $199,999) 41 14.3% 15 12.1% 26 16.0%
    Upper income (≥$200,000) 12 4.2% 3 2.4% 9 5.5%
There were no significant differences between the groups across demographic variables.
GPA: grade point average; SD: standard deviation; SI: suicidal ideation.
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TABLE 2
Frequency of responses to BDI suicide item 9 and level of depressive symptoms by response
BDI score BDI response N = 287 % BDI score minus BDI suicide item 9,
mean (SD)
0 I don't have any thoughts of killing myself. 163 56.8% 17.74 (4.88)
1 I have thoughts of killing myself, but I would not carry them out. 111 38.7% 19.94 (7.35)
2 I would like to kill myself. 11 3.8% 27.64 (9.28)
3 I would kill myself if I had the chance. 2 0.7% 19.50 (13.44)
BDI: Beck Depression Inventory; SD: standard deviation.
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TABLE 3
Comparing students with and without suicidal ideation across outcome variables
Total sample (N = 287)
With suicidal ideation Without suicidal ideation
n Mean (SD) n Mean (SD) t df
Psychiatric outcomes
BDI total score (minus item 9) 124 20.61 (7.85) 163 17.74 (4.88)
–3.59a,b 193.28
ASQ intensity total score 66 77.62 (29.33) 79 64.05 (26.84)
–2.91a 143
ASQ frequency total score 66 74.45 (29.51) 77 60.77 (26.02)
–2.95a 141
BAI total score 29 22.83 (12.49) 26 11.23 (7.13)
–4.28a,b 45.34
BHS total score 37 7.89 (4.20) 58 5.12 (3.72)
–3.37a 93
Functional outcomes
CPFQ total score 79 21.85 (5.30) 95 21.31 (5.79) –0.65 172
Q-LES-Q total score 54 46.69 (9.67) 78 48.47 (8.45) 1.12 130
GPA 105 3.23 (0.46) 137 3.25 (0.53) 0.28 240
ASQ: Anxiety Symptom Questionnaire; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; BHS: Beck Hopelessness Scale; CPFQ:
The Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire; GPA: grade point average; Q-LES-Q: Quality of Life
Enjoyment and Satisfaction Questionnaire–Short Form; SD: standard deviation.
a
<.01.
b
Equal variances not assumed.
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TABLE 4
Students with moderate to severe SI, mild SI, and no SI across psychiatric and functional outcomes
No SI (0 on BDI item 9) Mild SI (1 on BDI item 9) Moderate to severe SI (2 or 3
on BDI item 9)
ANOVA
n Mean (SD) n Mean (SD) n Mean (SD) F P
Psychiatric outcomes
BDI total score (minus
item 9)
163 17.74 (4.88) 111 19.94 (7.35) 13 26.38 (9.80) 8.07a .002a,b
ASQ intensity total score 79 64.05 (26.84) 58 75.34 (27.59) 8 94.13 (37.85) 5.90
.003b
ASQ frequency total score 77 60.77 (26.02) 58 71.98 (27.90) 8 92.38 (36.51) 6.38
.002b
BAI total score 26 11.23 (7.13) 23 21.35 (10.68) 6 28.50 (17.96) 8.80a .004a,b
BHS total score 58 5.12 (3.72) 36 7.81 (4.23) 1 11.00 (n/a) 5.97
.004b,c
Functional outcomes
CPFQ total score 95 21.3 (5.79) 68 21.93 (5.33) 11 21.36 (5.35) 0.26 .773
Q-LES-Q total score 78 48.47 (8.45) 49 47.56 (9.40) 5 38.20 (8.87) 3.20
.044b
GPA 137 3.25 (0.53) 95 3.21 (0.45) 10 3.44 (0.49) 0.99 .377
ANOVA: analysis of variance; ASQ: Anxiety Symptom Questionnaire; BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; BHS:
Beck Hopelessness Scale; CPFQ: The Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire; GPA: grade point
average; Q-LES-Q: Quality of Life Enjoyment and Satisfaction Questionnaire–Short Form; SD: standard deviation; SI: suicidal ideation.
aViolates homogeneity of variance. Welch statistic and associated P value reported.
b
Post hoc analyses between the 3 groups for significant outcome variables were significant for all groups except: •Q-LES-Q: No SI and mild SI
were not significantly different •ASQ intensity: Mild SI and moderate to severe SI demonstrated a trend toward significance (P = .075) •ASQ
frequency: Mild SI and moderate to severe SI demonstrated a trend toward significance (P = .05) •BAI: Moderate to severe SI and mild SI were not
significantly different.
c
Post hoc could not be performed due to cell size.
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